GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Nexus AG (XTER:NXU) » Definitions » ROE % Adjusted to Book Value

Nexus AG (XTER:NXU) ROE % Adjusted to Book Value : 2.61% (As of Dec. 2023)


View and export this data going back to 2000. Start your Free Trial

What is Nexus AG ROE % Adjusted to Book Value?

Nexus AG's ROE % for the quarter that ended in Dec. 2023 was 10.28%. Nexus AG's PB Ratio for the quarter that ended in Dec. 2023 was 3.94. Nexus AG's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 was 2.61%.


Nexus AG ROE % Adjusted to Book Value Historical Data

The historical data trend for Nexus AG's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nexus AG ROE % Adjusted to Book Value Chart

Nexus AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.02 1.93 1.62 2.52 2.49

Nexus AG Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.44 2.42 2.13 3.06 2.61

Competitive Comparison of Nexus AG's ROE % Adjusted to Book Value

For the Health Information Services subindustry, Nexus AG's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nexus AG's ROE % Adjusted to Book Value Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Nexus AG's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Nexus AG's ROE % Adjusted to Book Value falls into.



Nexus AG ROE % Adjusted to Book Value Calculation

Nexus AG's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=9.81% / 3.94
=2.49%

Nexus AG's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=10.28% / 3.94
=2.61%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Nexus AG ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Nexus AG's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Nexus AG (XTER:NXU) Business Description

Traded in Other Exchanges
Address
Irmastrasse 1, Donaueschingen, BW, DEU, 78166
Nexus AG is a software solution provider. The company functions through the Healthcare software and Healthcare service segments, which are responsible for providing information systems for hospitals, psychiatric, rehabilitation, and social institutions, IT services for IT operation specially in healthcare systems. The company derives a majority of its revenues from the Healthcare software segment. Its geographical segments are Germany, Switzerland/Lichtenstein, Netherlands, Poland, France, Austria, and other regions.